InvestorsHub Logo

Whalatane

09/08/21 10:31 PM

#353860 RE: Lemmiwinks #353858

Lem. If they have thoroughly checked all the readings , looked at subgroups, run their analysis etc etc by the end of Sept ...which Pdude believes ...then I agree with you .
If the trial execution and results are sound ...they should release the top line data at least... ASAP
Kiwi

Pharmacydude

09/09/21 7:32 AM

#353874 RE: Lemmiwinks #353858

Lem
Totally agree with you.
In his defence: when the Montréal Health Institute released a very generous appraisal of the benefits of colchicine in their trial he was one of the first and most vocal that without seeing all the data and having it peer reviewed it was not useful for making the clinical decision wether or not to start using colchicine in Covid pts. As it turned out docs that followed the PR version of the results were making clinically bad decisions based on partial information.
When ivermectin meta analysis data (which had been peer reviewed) started recommending that it be used he was one of the first I saw to vocally object to its use saying the data did not look right, that more information was needed to make a clinical decision because the numbers didn’t add up. Turns out at least 2 trials were fraudulent.
I agree that if his data is solid, the trial well designed and biases are minimized by being peer reviewed then something as important as an effective treatment for Covid should be released ASAP.
Unfortunately, thanks to social media and people like Raf, people no longer trust science or facts and every effort to present a solid, unified and broadly based message needs to be done just to give the science a chance of being accepted.
You know that Steve and the very well organized and well funded anti-V propaganda machine is just waiting to discredit ANY positive news.
I can’t help but see this delay as yet another concerning repercussion of the dangerously divergent path society is going down.